Bob Snow/Lancet

Sustainability, affordability, and equity of corporate drug donations: the case of Malarone.Shretta, R. Brugha, R. Robb, A. Snow, R. W.
Lancet, (2000). 355:1718-20

Averting a malaria disaster.White, N. J. Nosten, F. Looareesuwan, S. Watkins, W. M. Marsh, K. Snow, R. W. Kokwaro, G. Ouma, J. Hien, T. T. Molyneux, M. E. Taylor, T. E. Newbold, C. I. Ruebush, T. K, 2nd Danis, M. Greenwood, B. M. Anderson, R. M. Olliaro, P.
Lancet, (1999). 353:1965-7

Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa.Snow, R. W. Omumbo, J. A. Lowe, B. Molyneux, C. S. Obiero, J. O. Palmer, A. Weber, M. W. Pinder, M. Nahlen, B. Obonyo, C. Newbold, C. Gupta, S. Marsh, K.
Lancet, (1997). 349:1650-4

30 years of science and technology: the example of malaria.Marsh, K. Snow, R. W.
Lancet, (1997). 349:S1-2

Impact of UK malaria prophylaxis policy on imported malaria.Behrens, R. H. Bradley, D. J. Snow, R. W. Marsh, K.
Lancet, (1996). 348:344-5

Insecticide-treated bed nets in control of malaria in Africa.Snow, R. W. Lengeler, C. de Savigny, D. Cattani, J.
Lancet, (1995). 345:1056-7

Childhood deaths in Africa: uses and limitations of verbal autopsies.Snow, R. W. Armstrong, J. R. Forster, D. Winstanley, M. T. Marsh, V. M. Newton, C. R. Waruiru, C. Mwangi, I. Winstanley, P. A. Marsh, K.
Lancet, (1992). 340:351-5